These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 32822333

  • 1. Retrospective Analysis of Clinical Outcomes in Patients with Immunoglobulin A Nephropathy and Persistent Hematuria Following Renin-Angiotensin System Blockade.
    Chen J, Liu S, Xu H, Wang W, Xie Y, Tang W, Yuan Q, Zheng L, Lin L, Fu S, Shen J.
    Med Sci Monit; 2020 Aug 21; 26():e922839. PubMed ID: 32822333
    [Abstract] [Full Text] [Related]

  • 2. The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy.
    Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Nagata M, Tsuchimoto A, Hirakata H, Kitazono T, Tsuruya K.
    Clin Exp Nephrol; 2016 Oct 21; 20(5):689-698. PubMed ID: 26564155
    [Abstract] [Full Text] [Related]

  • 3. Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial.
    Ferraro PM, Ferraccioli GF, Gambaro G, Fulignati P, Costanzi S.
    Nephrol Dial Transplant; 2009 Jan 21; 24(1):156-60. PubMed ID: 18685141
    [Abstract] [Full Text] [Related]

  • 4. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    BMC Nephrol; 2017 Mar 14; 18(1):89. PubMed ID: 28292274
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of hydroxychloroquine versus leflunomide in patients with IgA nephropathy: a single-center experience.
    He WJ, Wang J, Liu N, Li GY, Zhu XW, Yao L, Liu LL.
    J Nephrol; 2024 May 14; 37(4):933-940. PubMed ID: 38225440
    [Abstract] [Full Text] [Related]

  • 6. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
    Li X, Liu Y, Lv J, Shi S, Liu L, Chen Y, Zhang H.
    Clin J Am Soc Nephrol; 2014 Mar 14; 9(3):484-9. PubMed ID: 24408121
    [Abstract] [Full Text] [Related]

  • 7. Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.
    Tesar V, Troyanov S, Bellur S, Verhave JC, Cook HT, Feehally J, Roberts IS, Cattran D, Coppo R, VALIGA study of the ERA-EDTA Immunonephrology Working Group.
    J Am Soc Nephrol; 2015 Sep 14; 26(9):2248-58. PubMed ID: 25677392
    [Abstract] [Full Text] [Related]

  • 8. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.
    Tanaka K, Moriyama T, Iwasaki C, Takei T, Nitta K.
    Clin Exp Nephrol; 2015 Oct 14; 19(5):815-21. PubMed ID: 25475403
    [Abstract] [Full Text] [Related]

  • 9. Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.
    Moriyama T, Nakayama K, Ochi A, Amemiya N, Tsuruta Y, Kojima C, Itabashi M, Takei T, Uchida K, Nitta K.
    Clin Exp Nephrol; 2012 Apr 14; 16(2):231-7. PubMed ID: 22038185
    [Abstract] [Full Text] [Related]

  • 10. Intrarenal Arterial Lesions Are Associated with Higher Blood Pressure, Reduced Renal Function and Poorer Renal Outcomes in Patients with IgA Nephropathy.
    Zhang Y, Sun L, Zhou S, Xu Q, Xu Q, Liu D, Liu L, Hu R, Quan S, Xing G.
    Kidney Blood Press Res; 2018 Apr 14; 43(2):639-650. PubMed ID: 29698975
    [Abstract] [Full Text] [Related]

  • 11. Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy.
    Sato H, Ichikawa D, Okada E, Suzuki T, Watanabe S, Shirai S, Shibagaki Y.
    PLoS One; 2021 Apr 14; 16(5):e0251294. PubMed ID: 34043669
    [Abstract] [Full Text] [Related]

  • 12. Short-term anti-proteinuric effect of tacrolimus is not related to preservation of the glomerular filtration rate in IgA nephropathy: A 5-year follow-up study.
    Yu MY, Kim YC, Koo HS, Chin HJ.
    PLoS One; 2017 Apr 14; 12(11):e0188375. PubMed ID: 29155873
    [Abstract] [Full Text] [Related]

  • 13. The beneficial effects of renin-angiotensin system blockades on 2 year outcomes in coronary artery ectasia patients.
    Wang Y, Wang Y, Yin D, Dou K, Wu Y, Song W.
    Curr Med Res Opin; 2017 Sep 14; 33(9):1677-1684. PubMed ID: 28598221
    [Abstract] [Full Text] [Related]

  • 14. Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial.
    Liu LJ, Yang YZ, Shi SF, Bao YF, Yang C, Zhu SN, Sui GL, Chen YQ, Lv JC, Zhang H.
    Am J Kidney Dis; 2019 Jul 14; 74(1):15-22. PubMed ID: 30922594
    [Abstract] [Full Text] [Related]

  • 15. Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.
    Yue C, Li G, Wen Y, Li X, Gao R.
    J Rheumatol; 2018 May 14; 45(5):655-662. PubMed ID: 29449503
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.
    Chen J, Xu H, Peng Z, Lin L, Li C, Zhu X, Liu S.
    Clin Exp Nephrol; 2020 Jan 14; 24(1):73-81. PubMed ID: 31605314
    [Abstract] [Full Text] [Related]

  • 17. Budesonide versus systemic corticosteroids in IgA Nephropathy: A retrospective, propensity-matched comparison.
    Ismail G, Obrişcă B, Jurubiţă R, Andronesi A, Sorohan B, Vornicu A, Sinescu I, Hârza M.
    Medicine (Baltimore); 2020 Jun 26; 99(26):e21000. PubMed ID: 32590815
    [Abstract] [Full Text] [Related]

  • 18. Are children with IgA nephropathy different from adult patients?
    Su B, Jiang Y, Li Z, Zhou J, Rong L, Feng S, Zhong F, Sun S, Zhang D, Xia Z, Feng C, Huang W, Li X, Chen C, Hao Z, Wang M, Qin L, Chen M, Li Y, Ding J, Bao Y, Liu X, Deng F, Cheng X, Zhang L, Zhang X, Yang H, Peng X, Sun Q, Deng L, Jiang X, Xie M, Gao Y, Yu L, Liu L, Gao C, Mao J, Zheng W, Dang X, Xia H, Wang Y, Zhong X, Ding J, Lv J, Zhang H.
    Pediatr Nephrol; 2024 Aug 26; 39(8):2403-2412. PubMed ID: 38578470
    [Abstract] [Full Text] [Related]

  • 19. Prospective trial of combined therapy with heparin/warfarin and renin-angiotensin system inhibitors in progressive IgA nephropathy.
    Ishii T, Kawamura T, Tsuboi N, Ogura M, Utsunomiya Y, Hosoya T.
    Contrib Nephrol; 2007 Aug 26; 157():114-9. PubMed ID: 17495447
    [Abstract] [Full Text] [Related]

  • 20. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec 26; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.